November 30, 2016 - By Marie Mckinney · 0 Comments
Triad Hospitals Inc (NYSE:TRI) institutional sentiment decreased to 0.87 in Q2 2016. Its down -0.03, from 0.9 in 2016Q1. The ratio fall, as 122 funds started new or increased positions, while 136 sold and trimmed stock positions in Triad Hospitals Inc. The funds in our partner’s database now have: 202.82 million shares, down from 217.27 million shares in 2016Q1. Also, the number of funds holding Triad Hospitals Inc in their top 10 positions decreased from 6 to 3 for a decrease of 3. Sold All: 26 Reduced: 110 Increased: 97 New Position: 25.
Thomson Reuters Corporation is a provider of news and information for professional markets. The company has a market cap of $32.09 billion.
Thomson Reuters Corp (NYSE:TRI) has risen 4.36% since April 27, 2016 and is uptrending. It has underperformed by 0.87% the S&P500.
Analysts await Thomson Reuters Corp (NYSE:TRI) to report earnings on February, 9. They expect $0.58 earnings per share, down 10.77% or $0.07 from last year’s $0.65 per share. TRI’s profit will be $428.26M for 18.73 P/E if the $0.58 EPS becomes a reality. After $0.54 actual earnings per share reported by Thomson Reuters Corp for the previous quarter, Wall Street now forecasts 7.41% EPS growth.
According to Zacks Investment Research, “Thomson Corporation is a leading provider of value-added information and technology to users in the fields of law, tax, accounting, financial services, higher education, reference information, corporate training and assessment, scientific research and healthcare.”
Montrusco Bolton Investments Inc. holds 5.63% of its portfolio in Thomson Reuters Corp for 2.19 million shares. Altrinsic Global Advisors Llc owns 4.02 million shares or 4.57% of their US portfolio. Moreover, Nexus Investment Management Inc. has 3.35% invested in the company for 436,425 shares. The Quebec – Canada-based Letko Brosseau & Associates Inc has invested 2.65% in the stock. Beutel Goodman & Co Ltd., a Ontario – Canada-based fund reported 5.75 million shares.#img1#
Ratings analysis reveals 0 of Thomson Reuters’s analysts are positive. Out of 9 Wall Street analysts rating Thomson Reuters, 0 give it “Buy”, 0 “Sell” rating, while 9 recommend “Hold”. The lowest target is $40 while the high is $55. The stock’s average target of $44.40 is 2.16% above today’s ($43.46) share price. TRI was included in 12 notes of analysts from July 29, 2015. The stock of Thomson Reuters Corp (NYSE:TRI) earned “Neutral” rating by Macquarie Research on Friday, August 26. As per Thursday, November 3, the company rating was reinitiated by JP Morgan. The firm has “Equal-Weight” rating given on Tuesday, August 23 by Barclays Capital. The firm earned “Buy” rating on Tuesday, August 18 by Zacks. The firm earned “Buy” rating on Wednesday, July 29 by TD Securities. Bank of America downgraded the stock to “Neutral” rating in Thursday, January 7 report. RBC Capital Markets maintained the stock with “Sector Perform” rating in Tuesday, February 9 report. FBR Capital downgraded Thomson Reuters Corp (NYSE:TRI) rating on Monday, October 26. FBR Capital has “Mkt Perform” rating and $42 price target. The company was downgraded on Monday, June 27 by TD Securities.
More recent Thomson Reuters Corp (NYSE:TRI) news were published by: Wsj.com which released: “Thomson Reuters to Cut 2000 Jobs in Restructuring” on November 01, 2016. Also Nasdaq.com published the news titled: “Thomson Reuters Corp (TRI) Ex-Dividend Date Scheduled for November 15, 2016” on November 14, 2016. Forbes.com‘s news article titled: “Thomson Reuters Stock Sees Short Interest Decline 21.6%” with publication date: November 28, 2016 was also an interesting one.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Marie Mckinney